Comment Number: 537778-00034
Received: 12/22/2008 2:03:51 PM
Organization: AARP
Commenter: David Sloane
State: DC
Agency: Federal Trade Commission
Rule: Emerging Health Care Competition and Consumer Issues
Attachments:537778-00034.pdf Download Adobe Reader

Comments:

Thank you for the opportunity to submit comments regarding a pathway for the Food and Drug Administration to approve generic biologics. AARP's comments are attached.